NDC 64764-0301 - Actos
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64764-0301
- Manufacturer
- Rebel Distributors Corp.
- Effective date
- 2010-09-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACTOS ® (pioglitazone hydrochloride) Tablets | Rebel Distributors Corp. | 2010-09-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| pioglitazone hydrochloride | ACTIVE INGREDIENT | JQT35NPK6C | ACTOS (PIOGLITAZONE HYDROCHLORIDE) TABLET [REBEL DISTRIBUTORS CORP.] | 7 | |
| pioglitazone | ACTIVE MOIETY | X4OV71U42S | ACTOS (PIOGLITAZONE HYDROCHLORIDE) TABLET [REBEL DISTRIBUTORS CORP.] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | a1112e4b-e9d5-13c3-e053-2995a90a6d0a | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | a0846e3e-68b2-fd55-e053-2995a90a673e | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | 8d5ac747-991f-30e4-e053-2a95a90a4780 | 2024-06-18 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Proficient Rx LP | f725cdaf-fc7a-40d6-ba64-1dccd1b25d7a | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | A-S Medication Solutions | 9fe57786-5c7d-4b11-8fb4-de341e2e5128 | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | A-S Medication Solutions | 4b5506c4-8cc2-44fb-ba2b-0e29fb73943d | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 312440 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | A-S Medication Solutions | 475c4f39-dd2a-48f9-a07c-9344bbda58a9 | 2023-04-04 | Boxed warning, Warnings, Adverse reactions | 312441 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | A-S Medication Solutions | 5f844e44-0f0d-4b28-9d34-b97780e1c6ec | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Macleods Pharmaceuticals Limited | 482cef76-0623-4b4f-a0ea-f008c97b2281 | 2022-12-26 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NorthStar RxLLC | 692e662a-3b31-42c3-a075-42abe44c74db | 2022-09-08 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Teva Pharmaceuticals USA, Inc. | c5c81c67-90cf-4e64-acb5-58b0358fa742 | 2021-07-01 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Aphena Pharma Solutions - Tennessee, LLC | f434ba0d-13f3-42ae-a2d5-cddb93fde1e8 | 2020-12-16 | Boxed warning, Warnings, Adverse reactions | 317573 JQT35NPK6C |
| PIOGLITAZONE | PIOGLITAZONE | Solco Healthcare LLC | 1b77dbeb-61d1-4df3-872b-2f4f75a110db | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 312441 312440 317573 |
| fd156adc-3174-44da-bff7-eeaef5983f18 | fd156adc-3174-44da-bff7-eeaef5983f18 | 2010-09-01 | Boxed warning, Warnings, Adverse reactions | fd156adc-3174-44da-bff7-eeaef5983f18 fd156adc-3174-44da-bff7-eeaef5983f18 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.